METTL13 is downregulated in bladder carcinoma and suppresses cell proliferation, migration and invasion

[1]  B. Chang,et al.  Contemporary Review , 2015 .

[2]  S. Zhou,et al.  Fentanyl inhibits proliferation and invasion of colorectal cancer via β-catenin. , 2015, International journal of clinical and experimental pathology.

[3]  D. Heitjan,et al.  CDK 4/6 Inhibitor Palbociclib (PD0332991) in Rb+ Advanced Breast Cancer: Phase II Activity, Safety, and Predictive Biomarker Assessment , 2014, Clinical Cancer Research.

[4]  J. Su,et al.  11-epi-Sinulariolide Acetate Reduces Cell Migration and Invasion of Human Hepatocellular Carcinoma by Reducing the Activation of ERK1/2, p38MAPK and FAK/PI3K/AKT/mTOR Signaling Pathways , 2014, Marine drugs.

[5]  P. Iversen,et al.  Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabine , 2014, Investigational New Drugs.

[6]  Siqi Liu,et al.  The other side of the coin: The tumor-suppressive aspect of oncogenes and the oncogenic aspect of tumor-suppressive genes, such as those along the CCND–CDK4/6–RB axis , 2014, Cell cycle.

[7]  R. Deng,et al.  A diterpenoid compound, excisanin A, inhibits the invasive behavior of breast cancer cells by modulating the integrin β1/FAK/PI3K/AKT/β-catenin signaling. , 2013, Life sciences.

[8]  A. Chatterjee,et al.  Extracellular matrix protein fibronectin induces matrix metalloproteinases in human prostate adenocarcinoma cells PC-3 , 2013, Cell communication & adhesion.

[9]  Yi‐Hsuan Lin,et al.  Overexpression of integrin-β1 in leiomyoma promotes cell spreading and proliferation. , 2013, The Journal of clinical endocrinology and metabolism.

[10]  A. Cataldi,et al.  Cyclin-Dependent Kinase Modulators and Cancer Therapy , 2012, BioDrugs.

[11]  C. Pashos,et al.  The health economics of bladder cancer , 2012, PharmacoEconomics.

[12]  M. Ohira,et al.  A novel potent tumour promoter aberrantly overexpressed in most human cancers , 2011, Scientific reports.

[13]  Stuart H. Orkin,et al.  A Myc Network Accounts for Similarities between Embryonic Stem and Cancer Cell Transcription Programs , 2010, Cell.

[14]  Michael Cookson.  The surgical management of muscle invasive bladder cancer: a contemporary review. , 2005, Seminars in radiation oncology.

[15]  I. Sesterhenn,et al.  World health organization classifications of tumours. pathology and genetics of tumours of the urinary system and male genital organs , 2005 .

[16]  C. Balch,et al.  AJCC Cancer Staging Manual. 6th ed , 2002 .

[17]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[18]  S. Groshen,et al.  Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  L. Sobin,et al.  World Health Organization classification of tumors , 2000, Cancer.

[20]  G. Landes,et al.  Analysis of human transcriptomes , 1999, Nature Genetics.

[21]  M. Suyama,et al.  Prediction of the coding sequences of unidentified human genes. XII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. , 1998, DNA research : an international journal for rapid publication of reports on genes and genomes.

[22]  J. Richie,et al.  Biology and management of bladder cancer. , 1990, The New England journal of medicine.